An anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy’s Laboratories (DRL), Hyderabad. Clinical trial results have shown that this molecule helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence.
An influenza pandemic is a global outbreak of a new influenza A virus. Pandemics happen when new (novel) influenza A viruses emerge which are able to infect people easily and spread from person to person in an efficient and sustained way. In the spring of 2009, a novel influenza A (H1N1) virus emerged. It was detected first in the United States and spread quickly across the United States and the world. This new H1N1 virus contained a unique combination of influenza genes not previously identified in animals or people. It should be noted that influenza virus testing is not required to make a clinical diagnosis of influenza in outpatients with suspected influenza, particularly during increased influenza activity when seasonal influenza A and B viruses are circulating in the local community.
SARS-CoV-2 already has a different mutation in circulation and several others have been predicted based on evolutionary benefits (Korber et al., 2020; Padhi and Tripathi, 2020). The kind of epidemiological demands that might arise in case a community transmission of a milder viral strain is swiftly followed by the appearance of a virulent one can be quite challenging.
As per reports, the accompanying psychologic distress in covid 19 patients are often ignored and not managed. There have also been reports of anxiety and acute depression leading to suicides in Covid care hospitals. Many of the patients, according to inputs coming in from different countries, have had to contend with isolation anxiety and distress due to fear of worsening of symptoms. Complications like respiratory distress, hypoxia, fatigue and insomnia and other symptoms have also been observed.
Trial courts deal most directly with people—lawyers, of course, but also litigants, witnesses, jurors, court reporters, probation and pretrial services officers, interpreters, security personnel, and members of the public who have important rights of access to proceedings. Trial judges have obligations under the Constitution and other laws to deal promptly with cases, especially with respect to criminal filings. And they have had to work out how to carry on their vital functions consistent with the best available public health guidance.
We make it clear that we have not directed the States/ Union Territories to compulsorily release the prisoners from their respective prisons. The purpose of our aforesaid order was to ensure the States/Union Territories to assess the situation in their prisons having regard to the outbreak of the present pandemic in the country and release certain prisoners and for that purpose to determine the category of prisoners to be released.
The vaccine is indicated for active immunization to prevent COVID-19 disease in individuals of ≥ 18 years of age. The vaccine should be administered intramuscularly in two doses of 0.5 ml each with interval of 21 days. (Day 0: Component I & Day 21: Component II). The vaccine has to be stored at -18°C. The vaccine comprises of two components I & II, which are not interchangeable. After careful consideration, the recommendations of the SEC have been accepted by the Drugs Control General (India). M/s DRL will import the vaccine for use in the country.
The international team recognized the impact of the epidemic on Wuhan, from affected individuals and communities to government officials, scientists and health workers. The team commended the engagement of all the professionals who had spent long hours analysing very large quantities of data to support its work. In conclusion, the team called for a continued scientific and collaborative approach to be taken towards tracing the origins of COVID-19.
Influenza is a highly infectious viral infection which occurs mainly in Winter. It is usually of sudden onset with fever, chills, painful muscles, headache, backache and cough. Influenza for most people is an unpleasant but self-limiting illness, the main symptoms lasting up to about a week. Treatment is symptomatic and those affected are advised to stay at home, rest and drink plenty of fluids.
National Clinical Management Protocol based on Ayurveda and Yoga for management of Covid-19 was released
The National Clinical Management Protocol based on Ayurveda and Yoga DATE: 06 OCT 2020 The National Clinical Management Protocol based on Ayurveda and Yoga for the management of Covid-19 was […]
Ministry of Home Affairs (MHA) has issued new guidelines today, for opening up of more activities in areas outside the Containment Zones. In these guidelines, which will come into effect from October […]